Propanc Biopharma (PPCB) Stock Chart & Stock Price History → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free PPCB Stock Alerts $0.0007 0.00 (0.00%) (As of 05/15/2024 ET) Add Compare Share Share ChartStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Propanc Biopharma Stock Price Performance5 Day Performance-30.00%1 Month Performance-46.15%3 Month Performance-84.09%6 Month Performance-94.31%Year-To-Date Performance-94.17%1 Year Performance-99.65% Receive PPCB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Propanc Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. PPCB Stock Chart for Thursday, May, 16, 2024 PPCB Chart by TradingView Propanc Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$0.00$0.00-22.22%$0.00$0.005.95 million shs$37,000.0005/14/2024$0.00$0.00$0.00$0.0014.35 million shs$47,000.0005/13/2024$0.00$0.00-10.00%$0.00$0.006.28 million shs$47,000.0005/10/2024$0.00$0.00+10.00%$0.00$0.003.30 million shs$57,000.0005/09/2024$0.00$0.00-33.33%$0.00$0.0014.81 million shs$52,000.0005/08/2024$0.00$0.00+25.00%$0.00$0.004.32 million shs$78,000.00 Get the Latest News and Ratings for PPCB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Propanc Biopharma and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$0.00$0.00+20.00%$0.00$0.004.38 million shs$63,000.0005/06/2024$0.00$0.00+25.00%$0.00$0.005.80 million shs$52,000.0005/03/2024$0.00$0.00$0.00$0.0014.68 million shs$42,000.0005/02/2024$0.00$0.00$0.00$0.0010.70 million shs$42,000.0005/01/2024$0.00$0.00-20.00%$0.00$0.001.19 million shs$42,000.0004/30/2024$0.00$0.00+11.11%$0.00$0.003.42 million shs$52,000.0004/29/2024$0.00$0.00-10.00%$0.00$0.0011.03 million shs$47,000.0004/26/2024$0.00$0.00-9.09%$0.00$0.003.06 million shs$52,000.0004/25/2024$0.00$0.00+10.00%$0.00$0.001.67 million shs$57,000.0004/24/2024$0.00$0.00-16.67%$0.00$0.00854,900 shs$52,000.0004/23/2024$0.00$0.00+9.09%$0.00$0.001.61 million shs$63,000.0004/22/2024$0.00$0.00$0.00$0.0012.45 million shs$57,000.0004/19/2024$0.00$0.00+10.00%$0.00$0.005.55 million shs$57,000.0004/18/2024$0.00$0.00-28.57%$0.00$0.0011.24 million shs$52,000.0004/17/2024$0.00$0.00+7.69%$0.00$0.004.44 million shs$68,000.0004/16/2024$0.00$0.00-7.14%$0.00$0.006.33 million shs$68,000.0004/15/2024$0.00$0.00-17.65%$0.00$0.0013.56 million shs$73,000.0004/12/2024$0.00$0.00$0.00$0.001.41 million shs$89,000.0004/11/2024$0.00$0.00-15.00%$0.00$0.001.83 million shs$89,000.0004/10/2024$0.00$0.00$0.00$0.001.80 million shs$104,000.0004/09/2024$0.00$0.00+33.33%$0.00$0.002.22 million shs$104,000.0004/08/2024$0.00$0.00-25.00%$0.00$0.005.05 million shs$78,000.0004/05/2024$0.00$0.00-20.00%$0.00$0.005.88 million shs$83,000.0004/04/2024$0.00$0.00-4.76%$0.00$0.0012.89 million shs$104,000.0004/03/2024$0.00$0.00-7.08%$0.00$0.005.22 million shs$110,000.0004/02/2024$0.00$0.00$0.00$0.008.24 million shs$118,000.0004/01/2024$0.00$0.00-29.38%$0.00$0.005.86 million shs$118,000.0003/29/2024$0.00$0.00$0.00$0.0011.38 million shs$167,000.0003/28/2024$0.00$0.00-23.81%$0.00$0.0011.38 million shs$167,000.0003/27/2024$0.00$0.00+55.56%$0.00$0.006.80 million shs$219,000.0003/26/2024$0.00$0.00-3.91%$0.00$0.006.46 million shs$141,000.0003/25/2024$0.00$0.00-7.87%$0.00$0.002.78 million shs$147,000.0003/22/2024$0.00$0.00+3.33%$0.00$0.006.53 million shs$162,000.0003/21/2024$0.00$0.00$0.00$0.002.07 million shs$156,000.00Wall Street legend who predicted 2021 tech crash issues new warning (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch his stock warning right here, 100% free of charge03/20/2024$0.00$0.00-3.23%$0.00$0.002.72 million shs$156,000.0003/19/2024$0.00$0.00+6.90%$0.00$0.006.27 million shs$162,000.0003/18/2024$0.00$0.00-34.09%$0.00$0.006.90 million shs$151,000.0003/15/2024$0.00$0.00+29.41%$0.00$0.008.29 million shs$229,000.0003/14/2024$0.00$0.00+25.93%$0.00$0.004.96 million shs$177,000.0003/13/2024$0.00$0.00-18.18%$0.00$0.005.19 million shs$141,000.0003/12/2024$0.00$0.00-16.46%$0.00$0.001.27 million shs$172,000.0003/11/2024$0.00$0.00-8.14%$0.00$0.001.77 million shs$206,000.0003/08/2024$0.00$0.00$0.00$0.002.53 million shs$224,000.0003/07/2024$0.00$0.00+43.33%$0.00$0.002.05 million shs$224,000.0003/06/2024$0.00$0.00+11.11%$0.00$0.001.48 million shs$156,000.0003/05/2024$0.00$0.00-6.90%$0.00$0.003.38 million shs$141,000.0003/04/2024$0.00$0.00-9.38%$0.00$0.001.77 million shs$151,000.0003/01/2024$0.00$0.00-5.88%$0.00$0.006.12 million shs$89,000.0002/29/2024$0.00$0.00-15.00%$0.00$0.002.56 million shs$95,000.0002/28/2024$0.00$0.00$0.00$0.002.96 million shs$111,000.0002/27/2024$0.00$0.00+11.11%$0.00$0.003.71 million shs$111,000.0002/26/2024$0.00$0.00+24.14%$0.01$0.002.09 million shs$100,000.0002/23/2024$0.00$0.00-27.50%$0.00$0.003.98 million shs$81,000.0002/22/2024$0.00$0.00+11.11%$0.00$0.001.81 million shs$111,000.0002/21/2024$0.00$0.00-16.28%$0.00$0.001.66 million shs$100,000.0002/20/2024$0.00$0.00-2.27%$0.00$0.00857,268 shs$120,000.0002/19/2024$0.00$0.00$0.00$0.002.86 million shs$123,000.0002/16/2024$0.00$0.00-6.38%$0.00$0.002.86 million shs$123,000.0002/15/2024$0.00$0.00+3.30%$0.01$0.001.32 million shs$131,000.00 Related Companies: Scopus BioPharma Stock Price Chart Statera Biopharma Stock Price Chart Amarantus BioScience Stock Price Chart Sunwin Stevia International Stock Price Chart NVN Liquidation Stock Price Chart Q BioMed Stock Price Chart Adhera Therapeutics Stock Price Chart Calithera Biosciences Stock Price Chart Advanced BioMedical Technologies Stock Price Chart ReNeuron Group Stock Price Chart Receive PPCB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Propanc Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PPCB) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Propanc Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
